NASD · Healthcare · Medical Devices · USA
Iradimed Corp is a small cap company (market value between $300 million and $2 billion) in the Medical Devices industry.
Iradimed develops, manufactures and distributes non-magnetic medical devices for use during MRI procedures, along with related accessories and disposables. The company's product portfolio includes IV infusion pump systems designed to safely deliver medications and vital sign monitoring equipment for critically ill and sedated patients. Iradimed sells to hospitals and acute care facilities across the United States and internationally.
From its FY2025 annual report (Form 10-K)
Intrinsic value, DCF valuation, financial health and value investing analysis for the Iradimed Corp stock.
Overvalued: intrinsic value $43.45 per share, market price $88.24, margin of safety -103.1% (as of 2026-10-20).
Discounting its cash flows at 9.6% (average of 3 methods) values the shares at $43.45; the price of $88.24 is 103% above that value, and 75% of that value comes from beyond year five.
Leak Score: 54/100 on 9 of 12 signals (Weak Signal).
17 more funds hold it; the full list is part of the paid plan.
All 142 Medical Devices stocks
36 more in this industry show a wider margin of safety.
IRMD is overvalued (as of the 2026-10-20 close). Discounting its cash flows at 9.6% (average of 3 methods) values the shares at $43.45; the price of $88.24 is 103% above that value, and 75% of that value comes from beyond year five.
$43.45 per share (as of the 2026-10-20 close), against a market price of $88.24. That is a margin of safety of -103.1%. The value is the average of the valuation methods that apply to this company, recomputed every night after the US close.
54 out of 100, which we rate "Weak Signal", on 9 of 12 value investing signals.